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Abstract
Objective: To estimate the cost-effectiveness of price subsidies on fortified
packaged complementary foods (FPCF) in reducing iodine deficiency, iron-
deficiency anaemia and vitamin A deficiency in Pakistani children.
Design: The study proceeded in three steps: (i) we determined the current lifetime
costs of the three micronutrient deficiencies with a health economic model; (ii) we
assessed the price sensitivity of demand for FPCF with a market survey in two
Pakistani districts; (iii) we combined the findings of the first two steps with the results
of a systematic review on the effectiveness of FPCF in reducing micronutrient
deficiencies. The cost-effectiveness was estimated by comparing the net social cost
of price subsidies with the disability-adjusted life years (DALY) averted.
Setting: Districts of Faisalabad and Hyderabad in Pakistan.
Subjects: Households with 6–23-month-old children stratified by socio-economic
strata.
Results: The lifetime social costs of iodine deficiency, iron-deficiency anaemia and
vitamin A deficiency in 6–23-month-old children amounted to production losses of
$US 209 million and 175 000 DALY. Poor households incurred the highest costs,
yet even wealthier households suffered substantial losses. Wealthier households
were more likely to buy FPCF. The net cost per DALY of the interventions ranged
from a return per DALY averted of $US 783 to $US 65. Interventions targeted at
poorer households were most cost-effective.
Conclusions: Price subsidies on FPCF might be a cost-effective way to reduce the
societal costs of micronutrient deficiencies in 6–23-month-old children in Pakistan.
Interventions targeting poorer households are especially cost-effective.
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Child undernutrition is endemic in Pakistan, with nearly
half of children under 5 years of age being stunted and
one in three being underweight(1,2). Undernutrition and
micronutrient deficiencies (MND) have severe health
consequences and are particularly harmful in early child-
hood. They irreversibly impair children’s physical and
cognitive development(3–5) and increase mortality risk(6).
UNICEF’s infant and young child feeding guidelines(7)
aim to maximize exclusive – and later to continue partial –
breast feeding, with the introduction of appropriate com-
plementary feeding after the sixth month. Complementary
feeding is important, as children in this age group undergo
rapid mental and physical development with a particularly
high need for micronutrient intake. Their micronutrient
stores are slowly depleted, yet their diet provides insuffi-
cient micronutrients(8,9). Even in rich countries, sufficient
micronutrient intake by 6–12-month-old children has
probably only been achieved with the widespread use of
fortified packaged complementary foods (FPCF)(10).
Fortification of staple foods cannot provide sufficient
nutrients to small children as staple foods are fortified at low
levels for the safety of the overall population. The limited
quantities of these foods consumed by 6–23-month-old
children are thus insufficient to meet their micronutrient
needs(8). Supplementation is well suited for targeting spe-
cific populations. However, compliance is often low(11).
FPCF, on the other hand, are characterized by standard-
ized micronutrient content tailored to the needs of young
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children. Moreover, packaged foods can use cheap and
well-developed distribution networks. This is especially
important for complementary foods for young children as
they need to be bought on a regular basis. Easy availability
was found to improve uptake(12). Two recent reports by
the Global Alliance for Improved Nutrition (GAIN) further
emphasize the importance of convenience, speed of pre-
paration and taste for the uptake of complementary infant
foods(13,14).
Cost-effectiveness evaluations inform decision makers on
whether the funds available are well spent. An intervention
is considered cost-effective when the monetary cost per unit
of outcome is below a predetermined threshold value.
We estimated the cost-effectiveness of subsidies on
FPCF for the reduction of iodine deficiency (IoD)(15), iron-
deficiency anaemia (IDA) and vitamin A deficiency (VAD)
in 6–23-month-old children in Pakistan. For this purpose, we
built a health economic model of the social cost of IoD, IDA
and VAD, and carried out a survey among 1764 Pakistani
households to assess their price sensitivity of demand.
Methods
Overview of study design
The present study estimated the effectiveness and cost-
effectiveness of subsidies on FPCF for the reduction of
MND in 6–23-month-old Pakistani children following the
approach developed in Plessow et al.(16). Figure 1 illus-
trates how the study combined three main steps. First, it
adapted a previous model of the societal costs of MND in
Pakistan(17) to the districts of Faisalabad and Hyderabad.
Second, a survey was conducted to assess the current
consumption of FPCF in these districts and the reaction to
hypothetical price discounts. Third, the results of the first
and second steps were combined with a systematic review
on the effectiveness of FPCF in reducing MND(18).
Cost-effectiveness was measured by the net societal cost
per disability-adjusted life year (DALY) averted. Net social
costs were determined by subtracting the averted medical
costs and production losses from the price subsidies.
Societal cost of micronutrient deficiencies
We calculated the current lifetime costs of IoD, IDA and
VAD in a birth cohort of children affected by these defi-
ciencies between the ages of 6 and 23 months. These costs
were calculated by adapting the model of the societal costs
of MND in Pakistan(17) to the districts of Faisalabad and
Hyderabad(19). The health and costs consequences of MND
in this age group are described in detail in the online
supplementary material (Section 1, Tables S1 and S2).
In summary, IoD may lead to mild to severe cognitive
impairment measured in loss of IQ (intelligence quotient)
points(15,20). IDA may lead to impaired cognitive develop-
ment and physical activity, while severe IDA may addi-
tionally lead to increased all-cause mortality(21–23). VAD may
lead to Bitot’s spots, night blindness, diarrhoea, measles and
all-cause mortality(24). Permanent cognitive impairment and
premature mortality lead to wage losses and DALY, whereas
reversible cognitive impairment leads to current DALY
only(17). Impaired physical activity, Bitot’s spots, night
blindness, diarrhoea and measles can be reversed with
micronutrient supplementation (as soon as the deficiency
disappears) and thus lead to current DALY only.
We assumed that children in the two districts were
distributed across socio-economic status (SES) strata
according to the province-level data of the Demographic
and Health Survey (DHS) 2012–13(19). The same approach
was applied to SES- and age-specific mortality rates, as
well as to the incidence of measles and diarrhoea. The
prevalence rates of IoD, IDA and VAD were calculated
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with a hypothetical buying experiment
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Fig. 1 Overview of the model linking micronutrient deficiencies to health economic outcomes
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based on the National Nutrition Survey (NNS) 2011(1). The
prevalence of IoD was calculated for school-age children
(SAC), using the established WHO cut-offs(15), as the NNS
does not provide spot urinary iodine concentration (UIC)
values for 6–23-month-old children(25). The calculation of
the population-attributable fraction of mental impairment
due to IoD was based on Zimmermann and Andersson(20)
and is described in detail in the appendix of Wieser
et al.(17). The treatment costs of diarrhoea and measles
were assessed in a household survey.
Household survey and hypothetical buying
experiment
To assess the current consumption of FPCF and the price
sensitivity of demand for FPCF, we carried out a household
survey. The survey took place between July and September
2015 in the districts of Faisalabad and Hyderabad located in
the provinces of Punjab and Sindh. These are the two most
populous provinces of Pakistan with a share of 46% and
28%, respectively, of the total population of 200 million.
Households were selected using a stratified two-stage
sample design based on the Pakistan Bureau of Statistics’
sampling frame. In a first step we randomly selected forty-
five primary sampling units, each comprising 200–250
households. In a second step we randomly selected
twenty-five households with at least one 6–23-month-old
child within each of the selected primary sampling units,
with stratification by three wealth classes (low, middle,
high). All interviews were conducted with the decision
maker responsible for food and beverage purchases.
The survey questionnaire (see online supplementary
material, Section 2) was composed of six parts assessing:
(i) household composition; (ii) current buying and serving
behaviour of FPCF; (iii) price sensitivity of demand for
FPCF; (iv) nutritional knowledge and attitudes regarding
child nutrition; (v) occurrence and treatment of specific
diseases like diarrhoea and acute respiratory infection; and
(vi) socio-economic characteristics of the household.
These socio-economic characteristics assessed in the sur-
vey were used to calculate a common wealth index
between our survey, the NNS(1) and the DHS(26). Based on
this wealth index, households were classified into ten
socio-economic strata (SES wealth index deciles) allowing
us to link the information collected in the survey with data
from the NNS(1) and the DHS(19).
The price sensitivity of demand for FPCF was assessed
with a hypothetical marketing experiment:
1. Respondents were asked to imagine that they were
eligible for a programme allowing them to buy FPCF
at a constantly discounted price until the child turns
2 years of age.
2. Respondents were then asked whether they would buy
these FPCF at a discount of 20%, 40%, 60% or 80%,
which had been randomly assigned in advance. If the
respondent was currently buying FPCF, the discount
related to the brand and market price of the FPCF
currently bought. If the respondent was currently not
buying FPCF, the discount related to de-branded 25 g
sachets of FPCF (see online supplementary material,
Fig. S1), which were shown together with information
on the recommended amount and duration of feeding.
3. If the respondents were willing to buy the FPCF at the
discounted price, they were asked to state the amount
of FPCF they would buy in a regular week. If
respondents were not willing to buy at the discounted
price, the next higher discount was offered repeatedly
until the highest discount of 80% was reached.
To avoid anchoring effects, we used only the information
on the first drawn discount to estimate the price sensitivity of
demand. We also applied an ex post correction (see online
supplementary material, Section 3) which has been shown
to be effective in reducing hypothetical bias(27).
Based on the marketing experiment we classified
households as ‘current buyers’, ‘potential buyers’ and
‘non-buyers’. Current buyers included the households
which had bought FPCF in the 7 d prior to the interview.
Potential buyers included the households which had not
bought FPCF in the days before the interview but claimed
they would do so at a discount of 20% to 80%. Non-
buyers included the households which had not bought
FPCF in the days before the interview and claimed that
they would not buy them even at a discount of 80%.
Cost-effectiveness estimation of price subsidies
The cost-effectiveness of subsidies on FPCF was estimated
in three steps. First, we estimated the demand effects of
price subsidies. Second, we translated these demand
effects into health effects using the results of a systematic
review of randomized controlled trials on the effectiveness
of FPCF in reducing IDA and VAD and applying the RDA
of iodine for IoD. Third, we calculated the cost-
effectiveness of the subsidies by running our model of
the lifetime costs of IoD, IDA and VAD in 6–23-month-old
children with and without the subsidies.
The demand effects of price subsidies were estimated
with a first difference model. This approach solves the
typical identification problems associated with a cross-
section estimation of demand. These problems were likely
to be severe, because most of the variation in price was
due to product variation. If wealthier households bought
both larger quantities and higher-quality products, a cross-
section estimation could lead to an upwards sloping
demand curve, because the price effect cannot be sepa-
rated from the effects of unobserved preferences. Fur-
thermore, the first difference model mitigates potential
problems arising from the failed randomization as it
eliminates all unobserved time-invariant individual effects
that are possibly correlated with the price of FPCF.
We estimated slightly different models depending on
the type of household. A log-linear model was applied for
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current buyer households (equation (1)) and a linear
model for potential buyer households (equation (2)).* We
thus estimated the following models:
Δ logðYiÞ=β0 ΔPi + β1 SESi ´ΔPið Þ +Δϵi (1)
and
ΔYi=β0 ΔPi + β1 SESi ´ΔPið Þ +Δϵi; (2)
where ΔYi=Yi1−Yi2, with Yi1 representing the weekly
amount of FPCF bought by household i at current market
prices (in grams), Yi2 representing the hypothetical
demand at discounted prices and ΔYi representing the
hypothetical change in demand as a result of the price
discount. Similarly, ΔPi=Pi1Pi2, with Pt1 being the price
for 25 g of FPCF (the size of one serving) paid by house-
hold i, Pi2 being the randomly drawn lower price and ΔPi
being the size of the price discount. As we expected the
response in demand to price changes to depend on
wealth, we included an interaction term between price
and wealth, represented by SESi, an ordinal variable
indicating the household’s wealth index decile. The
parameters of interest therefore are β0 and β1, capturing
the partial effect of price changes overall and depending
on wealth, respectively, on changes in demand. ϵi repre-
sents an error term at household level. Note that SESi
drops out by taking first differences.
Different robustness tests were performed. We first
compared the estimates of the parametric model as
described in equations (1) and (2) with the estimates of a
semi-parametric model including ten dummy variables for
SES and found that the variation in the demand effect
across SES is modelled fairly appropriately with our
baseline model assuming constant effects. We also con-
sidered different limited dependent variable models and
evaluated model performance based on 1000 cross-
validated out-of-sample predictions. The parametric
fixed-effects model performed best (see online supple-
mentary material, Section 4, Fig. S2 and Table S3). Models
including higher polynomials in price as well as the log
price were also tested. However, as we did not find any
significant improvements in the overall goodness-of-fit of
the model (as measured by adjusted R2, Akaike informa-
tion criterion and Bayesian information criterion), they
were rejected.
To translate demand effects into health effects we drew
on a systematic review of randomized controlled trials on
the effectiveness of FPCF in reducing IDA and VAD in
young children(18). The review shows that the daily pro-
vision of FPCF compared with non-fortified packaged
complementary foods leads to an increase in Hb level of
8·7 (95% CI 5·7, 11·6) g/dl and an increase in serum retinol
level of 3·7 (95% CI 1·3, 6·1) μg/dl. We assumed that daily
provision of 75 g of FPCF would have an identical effect on
Hb and serum retinol levels as the average effects assessed
in the systematic review. This amount of 75 g is higher
than the average amount of cereals provided in the studies
included in the systematic review. However, three 25 g
packages of the fortified infant cereals currently available
in Pakistan contain approximately the same amount of
iron provided on average in the systematic review. For the
effectiveness of FPCF in reducing IoD, we assumed that
the recommended daily dose of 75 g of FPCF would
contain the WHO RDA of iodine of 90 μg/d(15). We
calculated the respective change in UIC based on the
following equation proposed by the US Institute of Medi-
cine(28) and applied the UIC cut-offs for mild, moderate
and severe IoD as defined by WHO for SAC(15):
Daily iodine intake=UIC ðμg=lÞ=92 % ´ urine volume
ðlitres=kg per dÞ ´weight ðkgÞ: ð3Þ
Figure 2 uses IDA as an example to illustrate how the
demand effects are translated into changes in IoD, IDA
and VAD prevalence in a single SES. An intervention
increasing the consumption of FPCF by 75 g would shift
the Hb distribution to the right by 8·7 g/dl. As a result, the
prevalence of IDA would decrease. Changes in con-
sumption that are less than the recommended daily dose
are assumed to increase Hb levels proportionately.
The cost-effectiveness of an intervention was calculated
by first computing the net social costs of an intervention.
These net social costs correspond to the cost of the sub-
sidies minus the net present value of future production
losses in terms of lower future adult wage. The net social
60 70 80 90 100 110 120 130 140 150 160
Hb (g/l)
E
D
Fig. 2 Translating the demand effects into changes in iron-
deficiency anaemia (IDA) prevalence among 6–23-month-old
children from Faisalabad and Hyderabad districts, Pakistan.
The figure shows that an increase in the consumption of
fortified packaged complementary foods by 75 g (the
recommended daily dose) shifts the Hb distribution to the
right by 8·7g/l and thus reduces the share of children with IDA
by the area D. Area E represents the share of children with IDA
who remain deficient even after the maximum intervention
( , limit mild anaemia; , limit moderate anaemia; ,
limit severe anaemia; , average Hb before intervention; ,
average Hb with intervention)
* Note that a log-linear model for potential buyer households cannot be
estimated because their current demand is zero, as is the hypothetical
demand at the first drawn discount for some of the households.
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costs of the intervention were then divided by the amount
of DALY averted to obtain the cost-effectiveness ratio (see
online supplementary material, Section 5 and Fig. S3, for
illustrative examples). DALY averted are the difference
between the pre- and post-intervention DALY. DALY
correspond to the sum of life years lived with disability
and life years lost due to premature mortality. They
depend on the prevalence of MND, which is evaluated
with the biomarker of each micronutrient and its respec-
tive WHO threshold value.
Sensitivity analyses
To test the robustness of the results, we ran a probabilistic
and univariate sensitivity analysis. The probabilistic sensi-
tivity analysis creates a range of possible model outcomes
and determines the CI of the main model outcomes. The
univariate sensitivity analysis shows the impact of a possible
overestimation of the IoD prevalence. The results of these
sensitivity analyses are reported in the online supplementary
material (Section 8, Tables S5 and S6, Figs S6 to S8).
Results
Societal costs of micronutrient deficiencies
We first calculated the lifetime costs of a birth cohort of
children in the districts of Hyderabad and Faisalabad
affected by IoD, IDA and VAD between the ages of 6 and
23 months. The birth cohort included nearly half a million
children. The number of children per SES decreased with
increasing wealth (Table 1). Mortality rates decreased by a
factor of ten from the lowest to the highest SES.
Figure 3 illustrates the prevalence of VAD and IDA
across SES. The prevalence of VAD decreased from 51%
in the poorest to 41% among the wealthiest SES, while the
corresponding prevalence of IDA decreased from 46% to
41% (Fig. 3(a)). Moderate and severe IDA decreased with
wealth whereas mild IDA increased slightly (Fig. 3(b)).
Due to data limitations, the baseline prevalence rate of
IoD was not stratified by SES. The overall prevalence of
IoD among SAC in Pakistan was almost 40%, while the
prevalence of mild, moderate and severe IoD was at 26%,
11% and 2%, respectively(1).
Total societal costs amounted to monetary costs of $US
209 million and 175 000 DALY. Table 2 reports costs by
type as well as by time period in which they arise. Costs
were mainly driven by future production losses resulting
from impaired cognitive development due to IDA and IoD.
While DALY decreased considerably with increasing
wealth, production losses decreased only slightly (Fig. 4).
Results of the market survey
In total, 1764 households with a child aged 6–23 months
were contacted. Only eighty (4·5%) of these households
refused to participate, leading to an initial sample of 1684
interviews. Quality and plausibility checks led to the
exclusion of thirty-one (1·8%) observations, seventeen
Table 1 Distribution of birth cohort and mortality rate by socio-economic status (SES wealth index decile) among 6–23-month-old children
from Faisalabad and Hyderabad districts, Pakistan
SES1
(low) SES2 SES3 SES4 SES5 SES6 SES7 SES8 SES9
SES10
(high)
Cohort size
(in 1000s)
Share of birth cohort (%) 12·1 10·5 8·8 10·4 8·7 9·8 11·3 10·1 9·6 8·7 487·4
Yearly mortality rate (per 1000 children) 19·9 17·9 15·9 13·9 11·9 9·9 8·0 6·0 4·0 2·0
Authors’ calculations based on Demographic and Health Survey 2012–13 data, 2010 and 2011 population data(19,44,45).
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because of implausible values on quantity bought or pri-
ces paid and fourteen because of missing information on
hypothetical demand at discounted prices. Another 112
(6·7%) observations were excluded due to the ex post
correction applied to the hypothetical questions in the
marketing experiment. Their exclusion should not induce
any selection bias as our checks showed no significant
differences between included and excluded observations
in any of the characteristics except for nutritional knowl-
edge.* Table 3 shows the number of interviews and the
final sample size by wealth strata and district.
Table 4 gives an overview over the characteristics of the
surveyed households by wealth quintile. Table 4(a) shows
that nearly 80% of the households in the wealthiest quintile
were located in Faisalabad, while the lower quintiles were
more balanced with respect to district. Mothers were the
main decision makers regarding food choices for the child
and their share increased slightly with wealth. Virtually all
mothers were married and between 86% and 94% worked
at home. The share of illiterate mothers decreased from
49% in the lowest to 3% in the highest quintile, while the
share with a tertiary education increased from 1% to 57%.
Wage inequality was remarkable, with monthly household
earnings being eighteen times higher in the wealthiest
compared with the poorest 20% of the households.
Table 4(b) shows that wealthier households were more
often aware of MND, that they were more likely to have
received professional advice in terms of healthy child
nutrition and that they were more likely to use iodized salt.
Table 4(c) illustrates the current consumption of FPCF.
The share of current buyers increased markedly with
wealth. While only one in five of the poorest 20% of
households was serving FPCF, about one in two did so in
the wealthiest 20%. The relationship between wealth and
quantities served did not seem to follow a specific pattern.
The weekly quantities varied from 171 g in SES3–4 to 210 g
in SES7–8, corresponding to a share of 32–40% of the
recommended daily dose. Prices paid for FPCF increased
slightly with wealth, as wealthier households bought more
expensive products. The share of current non-buyers
Table 2 Societal costs of iron-deficiency anaemia (IDA), vitamin A deficiency (VAD) and iodine deficiency (IoD) in 6–23-month-old children
from Faisalabad and Hyderabad districts, Pakistan
DALY (in 1000s)
Production losses ($US, millions) Current Future Mortality Total
Future Mortality Total YLD YLD YLL DALY
IDA 153 6 159 10 93 14 117
VAD – 21 21 1 – 47 48
IoD 28 – 28 1 10 – 10
Total 182 27 209 11 103 61 175
YLD, years lived with disability; YLL, years of life lost.
The production losses and DALY do not overlap, hence reporting both does not lead to double counting(46,47). Future production losses occur during the future
working life. Current DALY occur in the 6–23-month period.
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(including potential buyers and non-buyers as defined in
the ‘Methods’ section) decreased from 78% in SES1–2 to
47% in SES9–10.
Table 4(d) reports the reasons for not buying FPCF
stated by current non-buyers, giving an indication of what
might motivate them to buy FPCF. Financial constraints
were the main reason for not buying FPCF among poorer
households (41% in SES1–2 and 0% in SES9–10). Weal-
thier households, although better informed about MND
(compare with Table 4(b)), mainly stated that homemade
food was better or even that FPCF were not healthy (7% in
SES1–2 and 17% in SES9–10). Digestive problems and
taste as reasons for not buying were mentioned more
often by wealthier than by poorer households (55% in
SES9–10 v. 35% in SES1–2).
Table 3 Sample size and area coverage
District Interviews (n) Final sample (n)
Faisalabad
Low wealth 268 249
Middle wealth 271 242
High health 275 262
Total 814 753
Hyderabad
Low wealth 284 256
Middle wealth 300 265
High health 286 267
Total 870 788
Overall 1684 1541
The table shows unweighted numbers of observations.
Authors’ survey of households with 6–23-month-old children from Faisalabad
and Hyderabad districts, Pakistan.
Table 4 Characteristics and current consumption behaviour, by socio-economic status (SES wealth index decile), in households with 6–23-
month-old children from Faisalabad and Hyderabad districts, Pakistan
SES decile
SES1–2 SES3–4 SES5–6 SES7–8 SES9–10
Mean SD Mean SD Mean SD Mean SD Mean SD
(a) Socio-economic characteristics
Hyderabad district 0·47 0·5 0·52 0·5 0·52 0·5 0·42 0·5 0·18 0·5
Mother is decision maker in food for child 0·85 0·4 0·82 0·4 0·90 0·3 0·93 0·3 0·92 0·3
Mother is married 1·00 0·1 1·00 0·1 1·00 0·0 1·00 0·0 1·00 0·0
Education of mother
Illiterate 0·49 0·5 0·24 0·4 0·12 0·3 0·04 0·2 0·03 0·2
Up to 9 years of school 0·34 0·5 0·27 0·5 0·21 0·4 0·17 0·4 0·04 0·2
10th class 0·11 0·3 0·29 0·5 0·32 0·5 0·25 0·4 0·13 0·3
11th, 12th class 0·06 0·2 0·12 0·3 0·19 0·4 0·21 0·4 0·23 0·4
(Post) graduate 0·01 0·1 0·08 0·3 0·16 0·4 0·33 0·5 0·57 0·5
Mother is not working/homeworker 0·86 0·4 0·94 0·2 0·95 0·2 0·96 0·2 0·94 0·2
Monthly household earnings ($US) 169 119 272 450 418 297 1373 2142 3032 2522
Age of the child (months) 13·7 4·8 13·5 4·9 13·6 4·9 13·9 5·1 14·2 4·9
Gender of the child: boy 0·53 0·5 0·53 0·5 0·53 0·5 0·45 0·5 0·51 0·5
(b) Nutritional knowledge
Received advice regarding child feeding 0·52 0·5 0·59 0·5 0·68 0·5 0·73 0·5 0·88 0·3
Heard about iron-deficiency anaemia? 0·29 0·5 0·45 0·5 0·51 0·5 0·72 0·5 0·86 0·4
Heard about vitamin A deficiency? 0·18 0·4 0·31 0·5 0·37 0·5 0·54 0·5 0·79 0·4
Heard about iodine deficiency? 0·32 0·5 0·51 0·5 0·63 0·5 0·73 0·4 0·91 0·3
Using iodized salt? 0·22 0·4 0·34 0·5 0·48 0·5 0·68 0·5 0·81 0·4
(c) FPCF current consumption
Current buyers (proportion) 0·22 0·4 0·37 0·5 0·47 0·5 0·44 0·5 0·53 0·5
Quantity bought (g/week) 190 191 171 152 186 160 210 248 174 145
Price paid per 25 g (PKR)* 18·8 5·2 19·2 5·1 19·4 4·8 21·5 5·0 22·8 4·3
Current non-buyers (proportion) 0·78 0·4 0·62 0·5 0·53 0·5 0·56 0·5 0·47 0·5
(d) Selected reasons for not buying (as proportion of current non-buyers, multiple answers possible)
Not affordable 0·41 0·5 0·25 0·4 0·12 0·3 0·05 0·2 0·00 0·0
Not healthy 0·07 0·3 0·07 0·3 0·06 0·2 0·10 0·3 0·17 0·4
Child doesn’t like it/digestive problems 0·35 0·5 0·38 0·5 0·42 0·5 0·48 0·5 0·55 0·5
Homemade food is better (as to variety) 0·10 0·3 0·13 0·3 0·20 0·4 0·33 0·3 0·55 0·5
Relatives, friends, doctors are against it 0·05 0·2 0·04 0·2 0·07 0·3 0·05 0·2 0·04 0·2
Not available 0·00 0·0 0·01 0·1 0·01 0·1 0·01 0·1 0·00 0·0
(e) Hypothetical experiment (as proportion of current non-buyers)
Would serve FPCF after having received product information
and if it were for free†
0·92 0·2 0·89 0·3 0·94 0·2 0·98 0·1 1·00 0·0
Buying at 20–80% discount (potential buyers) 0·53 0·5 0·41 0·5 0·37 0·5 0·32 0·5 0·06 0·2
Not buying at 20–80% discount (non-buyers) 0·47 0·5 0·59 0·5 0·63 0·5 0·68 0·5 0·94 0·2
Number of observations 339 322 323 324 345
FPCF, fortified packaged complementary foods.
The table shows weighted means and SD of selected characteristics for households separated by wealth quintiles from lowest (SES1–2) to highest (SES9–10). If
not indicated otherwise, the mean refers to the whole sample size (parts (a) and (b)). Observations were weighted according to district size.
*$US 1= 101·565 PKR (Pakistani Rupee).
†Accompanying information: ‘Many children suffer from micronutrient deficiencies and therefore cannot develop optimally. Suppose you were eligible for a
programme allowing you, as the mother of a child aged 6–23 months old, to buy packaged infant cereal at a reduced price. These infant cereals are a nutritious
baby food containing added minerals and vitamins. They support the healthy growth and development of your child. The added minerals and vitamins may help
protect your child from infections, eye problems, weak memory and ill health in general.’
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However, providing current non-buyers with a short
description of the product and its health benefits prior to
the marketing experiment increased the share of people
willing to serve FPCF if they were for free to 94% on
average and even more among wealthier households
(Table 4(e)). This is a clear indication that price-based
interventions along with product information for current
non-buyers might be an effective way to increase the
demand for FPCF. Table 4(e) also shows that the pro-
portion of households buying at a 20–80% discount
(potential buyers) was considerably lower than if FPCF
were provided for free. The proportion decreased from
53% in SES1–2 to 6% in SES9–10. Figure 5 illustrates the
distribution of buyer types across the wealth deciles (see
online supplementary material, Section 6 and Table S4 for
detailed results of the buying experiment).
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Fig. 5 Types of buyer of fortified packaged complementary foods by socio-economic status (SES wealth index decile) in households
with 6–23-month-old children from Faisalabad and Hyderabad districts, Pakistan (authors’ survey)
Table 5 Point estimates and marginal demand effects in households with 6–23-month-old children from Faisalabad and Hyderabad districts,
Pakistan
Log(demand) Demand (g/week)
Current buyers Potential buyers
Dependent variable Mean SE Mean SE
(a) Point estimates
Price (per 25 g) −0·058* 0·009 −9·33* 2·18
Price (per 25 g) ×SES 0·003* 0·001 −1·71* 0·53
Mean current demand 185·9 0·00
Mean price paid (per 25 g) 20·6 0·00
Number of observations 610 297
Adjusted R2 0·153 0·161
P value (F statistic) 0·00 0·00
(b) Marginal effects (g/week)
mfxSES1 10·47* 1·59 11·03* 1·77
mfxSES2 9·92* 1·39 12·74* 1·46
mfxSES3 8·61* 1·09 14·45* 1·30
mfxSES4 7·52* 0·86 16·15* 1·35
mfxSES5 7·50* 0·76 17·86* 1·59
mfxSES6 7·56* 0·69 19·56* 1·95
mfxSES7 8·65* 0·78 21·27* 2·37
mfxSES8 5·92* 0·60 22·98* 2·84
mfxSES9 5·60* 0·72 24·68* 3·32
mfxSES10 4·02* 0·70 26·39* 3·82
SES, socio-economic status; FPCF, fortified packaged complementary foods; PKR, Pakistani Rupee.
The table shows the results of the first difference model as specified in equations (1) and (2). Part (a) reports the point estimates of the price effect and the price
effect by SES on the quantity demanded. Part (b) shows the marginal demand effects for a price decrease of a 25 g sachet of FPCF by 1 PKR (corresponding to
an increase of 4–5%).
*Denotes statistical significance on the 1% level.
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Estimation of price sensitivity
Table 5 shows the point estimates for the models specified
in equations (1) and (2). The sign on the overall price
effect of demand is negative for both current and potential
buyers, indicating that quantity demand increased as price
decreased. However, the sign of the interaction effect
differs between the two groups. In contrast to the non-
buyer households, the demand effects decreased with
wealth among the households that already bought FPCF.
The marginal demand effects with respect to price by
SES denote the change in the weekly demand for FPCF (in
grams) in response to a price decrease of 1 PKR (Pakistani
Rupee; $US 1= 101·565 PKR) per 25 g (the size of one
serving). The weekly demand of the poorest decile of
households would, for example, increase by 10·47 g with a
price decrease of 1 PKR. With increasing wealth, the
marginal demand effects diverged between current buyers
and potential buyers. Price discounts were most effective
for low SES among current buyers, while they were most
effective for high SES among potential buyers. The share
of high-SES potential buyers was however very small. The
price elasticity of demand could be calculated only for
current buyers and ranged from −0·96 for SES1 to −0·60
for SES10.
Figure 6 presents the estimated demand effects for
different price subsidies. The average potential buyer
responded more strongly in absolute terms than the
average current buyer household (Fig. 6(a)). A price
subsidy of 20% would, for instance, lead to an increase in
the weekly quantity bought by 50 g for potential buyers
and by 16 g for current buyers. Figure 6(b) shows the
weighted average demand effects for the population as a
whole, as well as separately for current and potential
buyer households. An 80% subsidy led to an overall
average increase of 58 g/week per household (including
non-buying households). Although the differences
between current and potential buyers were smaller when
considering population shares, potential buyers still
responded stronger to price subsidies.
Effectiveness of subsidies
We calculated the effectiveness and cost-effectiveness for
different interventions differing in the size of the subsidy
(20% and 80%) as well as in the share of households
eligible for the subsidy. Interventions spanned from a 20%
price subsidy for the poorest 10% of the households
to an 80% price subsidy for the whole population. We also
considered interventions that provided all children
within a wealth decile with the recommended dose of 75 g
FPCF/d.
Table 6 shows the effectiveness of these interventions
with respect to the percentage of DALY averted. A 40%
subsidy for the poorest 20% (SES2) would for instance
avert 1·8% of DALY. Increasing the highest SES eligible for
a subsidy, increased the share of DALY averted. However,
the intervention becomes relatively less effective when
extending the intervention to higher SES as the share of
non-buyer households increases with wealth and the
prevalence of MND is lower in the higher SES. Increasing
the subsidy, on the other hand, leads to an approximately
proportionate increase in DALY averted.
We also evaluated two ‘for free’ scenarios to assess the
maximum possible effect. The first row in Table 6(b)
shows the effect of an intervention providing all 6–23-
month-old children in current and potential buyer
households with 75 g FPCF/d for free, under the assump-
tion that these 75 g/d were consumed in addition to the
amount already consumed. The second row shows the
maximum possible effect that could be achieved if all
children, including those in non-buyer households,
received 75 g FPCF/d for free. This intervention would
avert a maximum of 41·8% of DALY. These scenarios
mainly serve as comparison to the discounts because,
although they are highly effective, they also come
along with very high intervention costs (as shown in
Table 7).
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Fig. 6 (a) Estimated demand effects and (b) weighted average
demand effects of price subsidies on weekly demand for
fortified packaged complementary foods (FPCF) across buyer
types ( , current buyers; , potential buyers; , all households)
in households with 6–23-month-old children from Faisalabad
and Hyderabad districts, Pakistan (authors’ calculation)
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Cost-effectiveness of subsidies
Table 7 gives an overview of the results of our cost-
effectiveness estimations. The costs of the interventions
differed substantially between current buyers and poten-
tial buyers. While the price subsidies for potential buyers
were limited to the additional quantity of FPCF bought
because of the intervention, the price subsidies for current
buyers also included the amount of FPCF that would have
been bought anyway. This was a windfall gain for the
household but an ineffective cost for the provider as it did
not increase the consumption of FPCF (see online sup-
plementary material, Section 7, Fig. S5).
The costs per DALY averted ranged from $US 354/
DALY (20% price subsidy for SES1–2) to $US 1254/DALY
(80% price subsidy for SES1–8). Applying the cost-
effectiveness thresholds recommended by the WHO(29),
all the interventions appear highly cost-effective. The
recommendations define an intervention as highly cost-
effective if it meets a threshold per DALY averted of one
times the annual gross domestic product per capita, which
amounted to $US 1429 in Pakistan in 2015(30). If taking a
social perspective, which also considers the production
losses averted, all interventions appear cost-saving as they
not only averted DALY but also saved net social costs.
Table 6 Disability-adjusted life years (DALY) caused by iron-deficiency anaemia, vitamin A deficiency and iodine deficiency that are averted
by the price subsidy on fortified packaged complementary foods among 6–23-month-old children from Faisalabad and Hyderabad districts,
Pakistan
Highest SES decile eligible
SES1 SES2 SES3 SES4 SES5 SES6 SES7 SES8 SES9 SES10
(a)
20% subsidy 0·5 0·9 1·3 1·7 2·0 2·3 2·8 3·1 3·3 3·4
30% subsidy 0·8 1·3 1·8 2·3 2·8 3·3 4·0 4·5 4·8 4·9
40% subsidy 1·1 1·8 2·5 3·1 3·7 4·4 5·4 5·9 6·3 6·5
50% subsidy 1·3 2·2 3·1 4·0 4·7 5·6 6·7 7·4 7·9 8·1
60% subsidy 1·5 2·6 3·6 4·6 5·4 6·5 7·8 8·6 9·2 9·5
70% subsidy 1·7 3·0 4·1 5·3 6·2 7·4 8·9 9·8 10·5 10·8
80% subsidy 1·9 3·3 4·6 5·9 6·9 8·2 9·9 10·9 11·6 12·0
(b)
75 g/d for free 5·0 8·4 11·5 14·8 17·5 20·4 23·6 26·0 28·2 29·9
75g/d for free if no non-buyers 6·5 11·8 16·0 20·7 24·4 28·3 32·5 36·0 39·1 41·8
% non-buyers 29·3 44·8 34·6 38·8 35·3 31·9 32·6 42·4 42·8 45·9
SES, socio-economic status; FPCF, fortified packaged complementary foods.
Part (a) shows the percentage of DALY averted by interventions that differ in the size of the price subsidy and the SES eligible. Note that the values are
cumulative as the columns represent the highest SES eligible. Part (b) shows the results for two ‘for free’ scenarios. The first row shows the results for a scenario
in which all 6–23-month-old children living in a certain SES would be given 75 g FPCF/d for free in addition to the amount they already consumed. The last row
of part (b) goes one step further by assuming 100% compliance, i.e. that there are no non-buyer households. These results thus represent the maximum
possible effect.
Table 7 Cost-effectiveness of different interventions with fortified packaged complementary foods (FPCF) for one birth cohort of 6–23-
month-old children from Faisalabad and Hyderabad districts, Pakistan
Intervention SES eligible
Cost of intervention
($US, millions)
Production losses averted
($US, millions)
DALY
averted
Cost per DALY
averted ($US)
Net cost per DALY
averted ($US)
20% subsidy SES1–2 0·6 1·9 1648 354 − 783
50% subsidy 2·3 4·4 3918 587 − 538
80% subsidy 5·0 6·3 5801 866 − 214
75g/d for free 10·5 14·6 14733 714 − 276
20% subsidy SES1–4 1·2 3·5 2926 426 − 759
50% subsidy 4·7 8·1 6946 675 − 498
80% subsidy 10·0 11·6 10256 977 − 152
75g/d for free 19·4 26·8 25833 751 − 286
20% subsidy SES1–6 2·1 5·2 4097 506 − 773
50% subsidy 7·5 12·4 9722 773 − 498
80% subsidy 15·7 17·6 14348 1098 − 129
75g/d for free 28·4 40·3 35735 795 − 332
20% subsidy SES1–8 3·2 7·5 5480 590 − 781
50% subsidy 11·5 17·7 12966 888 − 474
80% subsidy 23·9 25·1 19050 1254 −65
75g/d for free 38·3 55·2 45571 841 −371
SES, socio-economic stratum (wealth index decile); DALY, disability-adjusted life year.
The table shows the cost, effectiveness and cost-effectiveness of selected price-based interventions as well as of an intervention that provided all 6–23-month-
old children of current and potential buyer households with the additional daily dose of 75 g.
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Interventions targeted at poorest household deciles
were most cost-effective because: (i) the prevalence of
IDA and VAD was higher; (ii) the share of non-buyers was
slightly lower, making the interventions more effective;
and (iii) the share of current buyers was lower, leading to
lower ineffective intervention costs.
Discussion
Summary and interpretation of results
We estimated the cost-effectiveness of price subsidies on
FPCF for the reduction of iodine, iron and vitamin A defi-
ciencies in 6–23-month-old Pakistani children. For this pur-
pose, we adapted a previous model of the societal costs of
micronutrient deficiencies in Pakistan(17) to the districts of
Faisalabad and Hyderabad, and carried out a survey
including a hypothetical marketing experiment among 1764
households. We then estimated the net cost per DALY
averted of different price subsidies covering different socio-
economic strata. Basing our calculation on the current MND
status in Pakistan, we account for other fortification and
supplementation programmes that are already in place.
We found that interventions targeting the poorest
households are more cost-effective than interventions with
a more extensive coverage because of the higher pre-
valence of MND, the lower levels of current consumption
and the higher price elasticity of demand in low SES. From
a societal perspective the most cost-effective intervention
is a 20% subsidy for the poorest 20% of the population,
with a net saving of $US 783 million per DALY averted.
While we found that interventions using FPCF could be
effective in reducing the social cost of MND, even the most
encompassing intervention could not eradicate IoD, IDA or
VAD. Providing all 6–23-month-old Pakistani children with
75 g of FPCF daily could reduce the DALY due to IoD, IDA
and VAD by 41·8%. However, an 80% subsidy for all
households could avert only 12·0% of DALY due to IoD,
IDA and VAD. The main reason for this difference was that
one in three households would not buy FPCF even at an
80% discount (share of non-buyers, compare with Fig. 5).
In comparison, the share of households who would not feed
FPCF if they were for free was small with 3·5% overall
(6·2% of current non-buyers). Price-based interventions
with accompanying product information thus seem to be an
effective instrument for demand creation but only in the
case of sufficiently high price discounts of over 80%.
Comparison with previous studies
Comparing our results with those of other studies is rather
difficult, due enormous differences in programme struc-
tures, delivery systems and other country-specific factors.
Fiedler et al.(31) revealed a substantial variation in the
estimated costs of fortification programmes and concluded
that these costs are severely underestimated by a majority
of the studies. A follow-up study by Fiedler and Macdo-
nald(32) assessed the intervention costs for four different
food vehicles and forty-eight high-priority countries,
including three interventions in Pakistan. Their results
were slightly lower than those of our most cost-effective
intervention, with estimated cost-effectiveness ratios as
follows: vitamin A fortification of sugar at $US 616 per
DALY averted; vitamin A fortification of vegetable oil at
$US 289 per DALY averted; and wheat flour fortification
with iron, folic acid and vitamin B12 at $US 341 per DALY
averted.
Possible under- and overestimation of
cost-effectiveness
Our results may underestimate the cost-effectiveness of
interventions for two reasons. First, FPCF provide children
with macronutrients and not only with micronutrients.
While the considerable cost for these macronutrients is
considered in our analysis, their effects are not. Dewey
and Adu-Afarwuah(33) have shown that interventions
providing additional energy positively affect growth, while
interventions relying purely on fortification do not.
Second, we included only iodine, iron and vitamin A in
our calculations, while there are a number of other
micronutrients that are contained in the fortified packaged
infant cereals currently available in Pakistan. We excluded
these other micronutrients and functional health outcomes
and morbidity, because the systematic reviews on the
effectiveness of complementary feeding interventions did
not find any evidence for other micronutrients, while the
evidence regarding functional health outcomes and mor-
bidity was scarce and inconclusive(18). However, this may
not only be due to the absence of effects in published
studies, but also due to a lack of reliable clinical studies.
On the other hand, we may overestimate the cost-
effectiveness for the following reasons. First, we did not
include programme implementation costs (including
accompanying information campaigns), which may be
substantial, especially for interventions targeting selected
groups only. Second, some of the children included in the
intervention already consumed large amounts of FPCF.
Therefore, the effect of FPCF observed in the systematic
review could be higher than real-world effects. Third,
subsidized FPCF may substitute other foods in the diet of
6–23-month-old children. However, the same is true for
the randomized trials regarding the effects of fortification
on Hb and serum retinol levels, on which our study is
based. While the effects on Hb and serum retinol levels
thus take account of the likely substitution effects, the
effects on iodine do not. However, as weaning foods (e.g.
porridge, mashed fruits and vegetables, rice) are poor in
native iodine, overestimation due to substitution effects
might be rather small. Fourth, by using spot UIC as a
biomarker of iodine intake we probably overestimate the
prevalence of IoD, due to high day-to-day within-person
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variance of UIC(34). Zimmermann et al.(34) were the first to
apply an external correction of the UIC distribution in
order to estimate the prevalence of IoD. We addressed this
possible overestimation with a univariate sensitivity ana-
lysis based on the findings of Zimmermann et al.(34) (see
online supplementary material, Section 8). Fifth, due to
lack of data regarding the UIC values from 6–23-month-old
children, we used the respective UIC values from SAC.
There are no recent studies regarding complementary
feeding practices in infants in Pakistan. Two studies(35,36)
using data from 2006–2007, as well as our conducted
survey in 2015 (see online supplementary material, Sec-
tion 6, Fig. S4), show that infants receive fortified formula
in addition to breast milk. Fortified formulas often include
iodine; as a result, iodine intake in infants may be higher
than in SAC, despite the fact that SAC may consume other
iodine-rich foods such as fish and iodized salt. Therefore,
we likely overestimate the prevalence of IoD.
Strengths and limitations
Our study has a number of strengths. A first strength is the
combination of three distinct steps: a health economic
model of the cost-consequences of MND in 6–23-month-
old children, a systematic review of the effectiveness of
FPCF in the reduction of IDA and VAD, and a household
survey assessing the price sensitivity for FPCF in house-
holds with children in the relevant age group. A second
strength is the application of health economic evaluation
methodologies to the field of public health nutrition. This
well-established methodological approach may contribute
substantially to the evaluation and design of cost-effective
nutritional interventions.
Our study also has a number of limitations. A first lim-
itation is the hypothetical nature of the marketing experi-
ment. Hypothetical questions assessing price sensitivity of
demand are usually subject to bias(37). However, our study
design avoids the most important pitfalls of hypothetical
questions: FPCF is a well-known and readily available
product, and bought by many of our respondents. Those
respondents not buying the product at the time of the
survey were provided with a description of FPCF and
shown an actual package to familiarize themselves with
the product. The use of such existing, clearly specified
products has been shown to improve the validity of pur-
chasing intentions(38). Obviously, a validation of our
results in a real-world setting would be extremely useful,
but it would require substantial financial and temporal
resources. A real-world marketing experiment, however,
could induce hoarding bias by encouraging respondents
to buy higher quantity of FPCF than what they would
normally buy. Hoarding bias should not be an issue in
the hypothetical experiment. A second limitation is the
uncertain accuracy of a number of assumptions in the
health economic model. Assumptions about the long-term
evolution of future wages and economic growth are
particularly difficult to sustain. However, this type of
modelling exercise is the only means of evaluating the
cost-effectiveness of interventions aimed at reducing the
lifetime consequences of MND in children(39). A third
limitation of our study is its short-term focus on increased
buying of FPCF, which is only one element of a sustained
change in complementary feeding practices. Other ele-
ments include the effective, repeated and coordinated
provision of information as well as the regulation of
marketing and promotion of these products(13).
Implementing interventions
Our results could be useful to policy makers constrained
by limited budgets and given cost-effectiveness thresholds.
For example, a budget of $US 5 million would be better
spent on a 50% subsidy for SES1–4 than on an 80% sub-
sidy for SES1–2, as it would be more cost-effective and
avert a larger number of DALY (see Table 7). On the other
side, a cost-effectiveness threshold of $US 1429/DALY
(equal to the gross domestic product per capita) implies
that the optimal intervention in terms of effectiveness
would be the one providing FPCF for free to SES1–8 at a
cost of $US 38·3 million. Policy makers would of course
also need to consider the cost of implementing the inter-
ventions in their decisions.
Embedding the proposed interventions into a private–
public partnership linked with public health policies and
nutrition policies such as the Scaling-Up Nutrition Initia-
tive(40,41) would be key for feasibility and sustainability. A
large-scale evaluation by GAIN has shown that such
partnerships with the private sector are required to reach
target consumers and drive demand for child nutrition
products(14). To ensure the maximum effectiveness of
complementary feeding interventions, they should be
ideally implemented in partnership with the health sector
along with nutritional education. This education should
cover the full range of child feeding practices from
exclusive breast-feeding to initiating complementary infant
food up to completely integrating the child into the
family’s dietary routine(42,43). Implementing the proposed
interventions through such partnerships could sub-
stantially reduce the huge social and economic burden of
child undernutrition in Pakistan.
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